Join PharmQD!

Become a member of our interactive community. Collaborate and network with your colleagues and trusted peers. Membership is free!

Communicate and Educate

Discuss new and important issues with your colleagues. Share your insights to help improve patient counseling.

Network With Peers

Join the conversation with trusted colleagues. Link up with professionals who share your ideas and insights.

Learn and Advance

Take free CE courses and rate courses for your peers. Find and apply for the newest jobs. Stay up-to-date on pharmacy news.

Unite

Share your experience with pharmacy students and technicians.

Create an account and receive access to the personalized box below, including your profile, bookmarks, friends, posts and more!

Join Now!

PharmNews

Featured News

FDA Approves Picato (ingenol mebutate) Gel for Topical Treatment of Actinic Keratosis - 01.26.2012

LEO Pharma announced that the U. S. Food and Drug Administration approved Picato (ingenol mebutate) gel (0.015%, 0.05%) for the topical treatment of actinic keratosis (AK).
AK is a precancerous condition caused by cumulative sun exposure that has the potential to progress to squamous cell carcinoma (SCC). Picato 0.015% gel is used once daily on the face and scalp for three consecutive days, and Picato 0.05% gel is used once daily on the trunk and extremities for two consecutive days. Picato gel is the first and only topical AK therapy that can be used for as little as two or three days.More »

Featured News

New Standard for Vitamin D Testing to Ensure Accurate Test Results - 01.26.2012

At a time of increasing concern about low vitamin D levels in the world's population and increased use of blood tests for the vitamin, scientists are reporting development of a much-needed reference material to assure that measurements of vitamin D levels are accurate. The report appears in ACS' journal Analytical Chemistry.More »

Featured News

Addition of Proton Pump Inhibitor to Treatment of Poorly Controlled Asthma in Children Does Not Improve Symptoms - 01.25.2012

Children without symptoms of gastroesophageal reflux whose asthma was being poorly controlled with anti-inflammatory treatment did not have an improvement in symptoms or lung function with the added treatment of the proton pump inhibitor lansoprazole, compared to patients who received placebo, according to a study in the January 25 issue of JAMA. Use of lansoprazole was associated with increased adverse events.More »

Featured News

First Detailed Data of Risk of Using Rasilez With Certain Blood Pressure-Lowering Drugs - 01.23.2012

Researchers at St. Michael's Hospital have published the first detailed figures showing the risk of using the prescription drug Rasilez in combination with certain other blood pressure-lowering medications.

The pharmaceutical company Novartis terminated a large, international clinical trial of the drug last month after finding an increased incidence after 18-24 months of non-fatal strokes, renal complications, high levels of potassium in the blood and low blood pressure.More »

Featured News

High Levels of MRSA Bacteria in U.S. Retail Meat Products, Study Suggests - 01.22.2012

Retail pork products in the U.S. have a higher prevalence of methicillin-resistant Staphylococcus aureus bacteria (MRSA) than previously identified, according to new research by the University of Iowa College of Public Health and the Institute for Agriculture and Trade Policy.More »

Advertisement

PharmTalk

New Blog Postings

Other Blog Posts

Prior Authorizations 01.23.12 0 comments Paul Badger
The Challenges of Integration 01.17.12 3 comments Paul Badger
Cataract: Options Other than Surgery 01.17.12 0 comments jamesparry
Something's Fishy about this Drug Research 01.16.12 1 comment jessevivian